| 今开：12.83 | 昨收：12.79 |
| 最高：13.3 | 最低：12.48 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4.58884214E8 |
Nevro(NVRO)02-24 06:45
$Nevro(NVRO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-019464 Act: 34 Size: 18 MB 网页链接查看全文
Nevro(NVRO)03-02 07:05
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000104 Size: 4 KB 网页链接查看全文
Nevro(NVRO)03-02 07:05
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000105 Size: 4 KB 网页链接查看全文
Nevro(NVRO)03-06 05:25
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000125 Size: 4 KB 网页链接查看全文
Nevro(NVRO)03-06 05:25
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000126 Size: 4 KB 网页链接查看全文
Nevro(NVRO)03-07 07:55
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000138 Size: 6 KB 网页链接查看全文
Nevro(NVRO)03-07 07:55
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000137 Size: 6 KB 网页链接查看全文
Nevro(NVRO)03-12 04:55
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000147 Size: 6 KB 网页链接查看全文
Nevro(NVRO)03-12 04:55
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000144 Size: 6 KB 网页链接查看全文
Nevro(NVRO)04-13 04:55
$Nevro(NVRO)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-044100 Act: 34 Size: 6 MB 网页链接查看全文
桑恩博雷的杰米2017-11-08 10:08
NVRO本季财报跳票了。35%的增速并不让市场满意，管理层的Q4展望也比较保守。于是市场很干脆的报以10%的下跌。
这就牵出来一个问题，增速跳票是产品不行还是销售不行，还是两者都责任，亦或者简单的市场预期太高了？
我认为产品是很行的。专业性上我认为FDA的优选标签不是白给的，神经科学...查看全文
funinvest2017-11-07 21:18
$Nevro Corp.(NVRO)$
1；* Nevro Corp <NVRO.N>: Canaccord Genuity cuts price target to $110 from $120
2；* Nevro Corp <NVRO.N>: Leerink raises price target to $110 from $105
3；* Nevro Corp <NVRO.N>: Morgan Stanley cuts target price to $93 fro...查看全文
mountaineer2017-11-07 17:13
$Nevro Corp.(NVRO)$ 环比销售增长了6%，竞争对手是持平或稍降，所以市场份额同比是提高了。同比确实不大灵。竞争对手看到SCS增长机会，销售砸钱力度大大加大。查看全文
funinvest2017-11-07 11:48
$Nevro Corp.(NVRO)$ 1，关键问题肯定是收入增速太低。
2，SGA增速高，都是人头费，可以理解，毛利率也提高了。
3，按照$310 to $320 million的指引，Q4收入是90m左右，环比增速也就是12%。查看全文
桑恩博雷的杰米2017-11-07 07:15
$Nevro Corp.(NVRO)$ 预期中的增速提升没有来。等着听CEO怎么说。人头是招够了，但不够成熟？另一个更让人不好接受的解释是市场没有想象的那么大。查看全文
智通财经APP获悉，鉴于多数大型医疗科技公司已公开表示有意在该领域进行收购，摩根大通分析师Robbie Marcus列出了潜在的收购目标，包括：英特格拉生命科学(IART.US)、Nevro (NVRO.US)、纽瓦索器材(NUVA.US)、Silk Road Medical (SILK.US... 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000207 Size: 4 KB 网页链接
$Nevro(NVRO)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-044100 Act: 34 Size: 6 MB 网页链接
$Nevro(NVRO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-044108 Act: 34 Size: 1 MB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000204 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000200 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000201 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000202 Size: 8 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000203 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000159 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000144 Size: 6 KB 网页链接